Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2012 006 439.0 |
96 | EP file number | EAKZ | 12 18 5728.8 |
97 | EP publication number | EPN | 2711426 |
54 | Designation/title | TI | Expressionsvektoren mit chimärem Cytomegalieviruspromotor und Verstärkersequenzen |
51 | IPC main class | ICM (ICMV) | C12N 15/85 (2006.01) |
22 | DE application date | DAT | Sep 24, 2012 |
96 | EP application date | EAT | Sep 24, 2012 |
43 | Date of first publication | OT | Mar 26, 2014 |
| Date of publication of grant | PET | Apr 8, 2015 |
71/73 | Applicant/owner | INH | Lonza Biologics plc, Slough, Berkshire, GB |
72 | Inventor | IN | Payne, Tom, Cambridge CB1 3PZ, GB; Young, Robert, London NW2 1SR, GB; Feary, Marc, NewmarketSuffolk CB8 0PX, GB |
| Address for service | | Lonza Biologics plc, Slough, Berkshire SL1 4DX, GB |
| Due date | FT FG | Sep 30, 2025 Annual fee for the 14th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002711426 Searchable text:
EP000002711426 Original document:
EP000002711426B1 Searchable text:
EP000002711426B1 |
43 | Date of first publication | EVT | Mar 26, 2014 |
| Date of the first transfer into DPMAregister | EREGT | May 8, 2014 |
| Date of the (most recent) update in DPMAregister | REGT | Oct 8, 2024 (Show all update days)(Hide all update days)- Oct 8, 2024
- Oct 6, 2023; Oct 8, 2022; Sep 8, 2021; Aug 11, 2020; Sep 14, 2019; Aug 25, 2018; Aug 1, 2017; Jun 1, 2017; Jul 16, 2016; Apr 21, 2016; Mar 17, 2016; Aug 15, 2015; May 21, 2015; Apr 10, 2015; Apr 9, 2015
- Historical data not available for this/these date(s)
- May 8, 2014
- Date of the first transfer into DPMAregister
|